×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IKT – inhibikase therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IKT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:18 am
ikt
Inhibikase Therapeutics (NASDAQ:IKT) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
Inhibikase Therapeutics (NASDAQ:IKT) was upgraded by analysts at Zacks Research to a "hold" rating.
12/2
06:16 am
ikt
Inhibikase Therapeutics (NASDAQ:IKT) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Medium
Report
Inhibikase Therapeutics (NASDAQ:IKT) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
11/20
10:12 pm
ikt
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Medium
Report
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
11/20
09:54 pm
ikt
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
11/20
06:04 pm
ikt
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Medium
Report
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
11/20
04:12 pm
ikt
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
11/20
04:01 pm
ikt
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
Low
Report
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
11/14
05:41 pm
ikt
Inhibikase Therapeutics GAAP EPS of -$0.13 [Seeking Alpha]
Low
Report
Inhibikase Therapeutics GAAP EPS of -$0.13 [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
8/14/2025
04:50 pm
IKT
inhibikase therapeutics, inc.
MISS
Report
2.3%
inhibikase therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/24
03:47 pm
ikt
Form 4 Inhibikase Therapeutics, For: Nov 21 Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
Low
Report
Form 4 Inhibikase Therapeutics, For: Nov 21 Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.
11/21
04:28 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Nov 20
Medium
Report
Form 8-K Inhibikase Therapeutics, For: Nov 20
11/21
04:24 pm
ikt
Form 424B5 Inhibikase Therapeutics,
Medium
Report
Form 424B5 Inhibikase Therapeutics,
11/20
04:35 pm
ikt
Form 424B5 Inhibikase Therapeutics,
Medium
Report
Form 424B5 Inhibikase Therapeutics,
11/20
04:12 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Nov 20
Medium
Report
Form 8-K Inhibikase Therapeutics, For: Nov 20
11/14
04:43 pm
ikt
Form 10-Q Inhibikase Therapeutics, For: Sep 30
Low
Report
Form 10-Q Inhibikase Therapeutics, For: Sep 30
11/14
04:31 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Nov 14
Low
Report
Form 8-K Inhibikase Therapeutics, For: Nov 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: